Potassium Fluoride → HCID 66608418, 화합물

HRID 1625725

반응식

HRID 1625725 반응식
Br[CH2:2][C:3]1[N:4]=[N:5][N:6]([C@@H:8]2[O:25][C@H:24]([CH2:26][O:27][C:28](=[O:30])[CH3:29])[C@@H:19]([O:20][C:21](=[O:23])[CH3:22])[C@H:14]([O:15][C:16](=[O:18])[CH3:17])[C@H:9]2[O:10][C:11](=[O:13])[CH3:12])[CH:7]=1.C([Sn](CCCC)(CCCC)[C:36]1[CH:41]=[CH:40][C:39]([CH2:42][CH3:43])=[CH:38][CH:37]=1)CCC.[F-].[K+]>O1CCCC1.C(OCC)(=O)C.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:42]([C:39]1[CH:40]=[CH:41][C:36]([CH2:2][C:3]2[N:4]=[N:5][N:6]([C@@H:8]3[O:25][C@H:24]([CH2:26][O:27][C:28](=[O:30])[CH3:29])[C@@H:19]([O:20][C:21](=[O:23])[CH3:22])[C@H:14]([O:15][C:16](=[O:18])[CH3:17])[C@H:9]3[O:10][C:11](=[O:13])[CH3:12])[CH:7]=2)=[CH:37][CH:38]=1)[CH3:43]

참가 물질

7

반응물 3

HCID 522689Potassium FluorideHCID 60041267Tributyl-(4-ethylphenyl)stannaneHCID 666083074-(bromomethyl)-1-(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)-1,2,3-triazole

생성물 1

HCID 66608418HCID 66608418, 화합물수율 17.1%

시약·촉매·용매 3

HCID 178418397HCID 178418397, 화합물촉매HCID 8028Tetrahydrofuran용매HCID 8857Ethyl Acetate용매

반응 조건

온도
70 °C

실험 절차

A solution of 4-(bromomethyl)-1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-1,2,3-triazole 32 (500 mg) (See Federico G. H. et al., J. Med. Chem. (1979) 29, 496), tri-n-butyl(4-ethylphenyl)tin 33 (604 mg) and tetrakis(triphenylphosphine)palladium (0) (59 mg) in tetrahydrofuran (10 ml) was stirred under heating at 70° C. for 12 hours under argon atmosphere. The reaction mixture was cooled to room temperature, diluted with ethyl acetate, and then, an aqueous potassium fluoride solution was added thereto and the mixture was stirred at room temperature for one hour. Insoluble materials were filtered off, and the filtrate was washed with water, and dried over magnesium sulfate. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=90:10-50:50) to give 4-(4-ethylphenylmethyl)-1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-1,2,3-triazole 34 (90 mg) as a colorless solid. APCI-Mass m/Z 518 (M+H).

후처리

  1. temperatureThe reaction mixture was cooled to room temperature
  2. filtrationInsoluble materials were filtered off
  3. washthe filtrate was washed with water
  4. dry with materialdried over magnesium sulfate
  5. customThe solvent was evaporated under reduced pressure
  6. customThe residue was purified by silica gel column chromatography (hexane:ethyl acetate=90:10-50:50)

출처 및 근거

ORD 기록
ord-4c60b556211e479ba1a287acf006ada8
출처 데이터셋
uspto-grants-2014_07
특허 번호
US08785403B2

연결된 노트

불러오는 중…